We are facing an unprecedented mental health crisis.
Communities locally and globally continue to suffer from growing numbers of “deaths of despair,” including suicide, drug overdose, and alcohol abuse.
According to the CDC, depression is the leading cause of disability in the US among people aged 15-44, and anxiety disorders are the most common mental illness in the US, affecting 40 million adults.
Traditional psychiatric treatments (antidepressants and anti-anxiety medications) have significant negative side effects – including emotional numbness, migraines, loss of sexual appetite, weight gain, drowsiness, addiction, insomnia, and suicidal ideation – and lack innovation in recent years. The time is right for psychedelic therapy.